(Q38902884)

7 September 2017

title

Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients (English)

1 reference

7 September 2017

1 reference

Imen Ben-Mustapha

1

1 reference

7 September 2017

Khaoula Ben-Farhat

2

1 reference

7 September 2017

Naouel Guirat-Dhouib

3

1 reference

7 September 2017

Emna Dhemaied

4

1 reference

7 September 2017

Beya Larguèche

5

1 reference

7 September 2017

Meriem Ben-Ali

6

1 reference

7 September 2017

Jalel Chemli

7

1 reference

7 September 2017

Jihène Bouguila

8

1 reference

7 September 2017

Lamia Ben-Mansour

9

1 reference

7 September 2017

Fethi Mellouli

10

1 reference

7 September 2017

Monia Khemiri

11

1 reference

7 September 2017

Mohamed Béjaoui

12

1 reference

7 September 2017

Mohamed-Ridha Barbouche

13

1 reference

7 September 2017

language of work or name

1 reference

13 January 2013

1 reference

Journal of Clinical Immunology

7 September 2017

published in

1 reference

7 September 2017

volume

33

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

865-870

1 reference

Assembly, transport, and function of MHC class II molecules

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

The bare lymphocyte syndrome and the regulation of MHC expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Primary immunodeficiency diseases in Egyptian children: a single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Two complementation groups account for most cases of inherited MHC class II deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

[Prevalence of Pneumocystis jiroveci pneumonia in Tunisian primary immunodeficient patients].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

[Cryptosporidium infection in patients with major histocompatibility complex class II deficiency syndrome in Tunisia: description of five cases].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Mutation in the class II trans-activator leading to a mild immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Mixed origin of the current Tunisian population from the analysis of Alu and Alu/STR compound systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Primary immunodeficiencies in highly consanguineous North African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9863-8

Frequency and Clinical Manifestations of Patients with Primary Immunodeficiency Disorders in Iran: Update from the Iranian Primary Immunodeficiency Registry

21 January 2018

1 reference

12 December 2020

MHC and T cell development

1 reference

12 December 2020

Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom

1 reference

12 December 2020

Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome

1 reference

12 December 2020

[How should an immunodeficiency be explored?]

1 reference

12 December 2020

Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile

1 reference

12 December 2020

10.1007/S10875-013-9863-8

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1008689646

0 references

1 reference